 |
|
Ovarian Cancer Prevention (PDQ®)
[ patient ] [ health professional ]
Expert-reviewed information summary about factors that may influence the risk of developing ovarian cancer and about research aimed at the prevention of this disease.
Preventive Surgery Can Cut Risk of Ovarian and Fallopian Tube Cancers for BRCA1, BRCA2 Carriers
Women who are at high risk of ovarian cancer because they carry mutated BRCA1 and BRCA2 genes can reduce by about 80 percent their risk of developing this and other cancers of the reproductive organs by having preventive surgery to remove their ovaries and fallopian tubes, according to the July 12, 2006, Journal of the American Medical Association.
Ovary Removal Linked to Cognitive Problems, Dementia
Women who had one or both ovaries removed before menopause for noncancer reasons faced an increased risk of developing cognitive problems or dementia later in life, according to the Sept. 11, 2007, issue of Neurology.
Genetics of Breast and Ovarian Cancer (PDQ®)
[ health professional ]
Expert-reviewed information summary about the genetics of breast and ovarian cancer, including information about specific genes and family cancer syndromes. The summary also contains information about interventions that may influence the risk of developing breast and ovarian cancer in individuals who may be genetically susceptible to these diseases. Psychosocial issues associated with genetic testing are also discussed.
BRCA1 and BRCA2: Cancer Risk and Genetic Testing
A fact sheet about the BRCA1 and BRCA2 genes, how BRCA1 and BRCA2 gene mutations (changes) affect a person's risk of cancer, genetic testing for cancer risk, interpreting test results, and the benefits and risks of genetic testing. National Cancer Institute Fact Sheet 3.62.
Understanding Gene Testing
Illustrates what genes are, explains how mutations occur and are identified within genes, and discusses the benefits and limitations of gene testing for cancer and other disorders.
Search: Cancer Genetics Services Directory
Directory of professionals who provide services related to cancer genetic risk assessment, counseling, and testing.
Cancer Genetics Overview (PDQ®)
[ health professional ]
Expert-reviewed information summary in which the validity and utility of genetic tests are discussed and important genetic terms are defined.
Oral Contraceptives Reduce Long-Term Risk of Ovarian Cancer
Since they were first licensed nearly 50 years ago, birth control pills containing estrogen have prevented some 200,000 cases of ovarian cancer world-wide, estimate the authors of a study published January 26, 2008, in The Lancet.
Oral Contraceptives and Cancer Risk: Questions and Answers
A fact sheet about research on the risk of developing cancer of the breast, cervix, liver, and ovary from the use of oral contraceptives. National Cancer Institute Fact Sheet 3.13
Risk of Ovarian Cancer from Hormone Therapy Confirmed
Women who have taken hormone therapy are at a higher risk of developing ovarian cancer than women who have not, according to a Danish study published in the July 15, 2009 issue of the Journal of the American Medical Association.
Menopausal Hormone Use
A collection of material about research related to the risks and benefits of hormone medication taken to ease symptoms associated with menopause.
Ovarian Epithelial Tumors Traced to Fallopian Tubes
The source of disease in many cases of the most aggressive form of ovarian cancer, serous carcinoma, may not be the ovary at all, but rather the fimbria of the fallopian tube, according to findings presented at the 2008 American Association for Cancer Research annual meeting.
|
|
|
